BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6954554)

  • 1. Inhibition of hormone-stimulated human fat cell-lipolysis by prostaglandin E2 and its synthetic analogue sulprostrone.
    Kather H
    Prostaglandins Leukot Med; 1982 May; 8(5):525-9. PubMed ID: 6954554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of prostaglandin E2 on adenylate cyclase activity and lipolysis in human adipose tissue.
    Kather H
    Int J Obes; 1981; 5(6):659-63. PubMed ID: 7319686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human fat cell lipolysis is primarily regulated by inhibitory modulators acting through distinct mechanisms.
    Kather H; Bieger W; Michel G; Aktories K; Jakobs KH
    J Clin Invest; 1985 Oct; 76(4):1559-65. PubMed ID: 2997284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the stimulatory effect of adrenaline and prostaglandin E1 on the human fat cell adenylate cyclase by adenosine.
    Kather H; Simon B
    Horm Metab Res; 1980 Apr; 12(4):169-72. PubMed ID: 7390397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biphasic effects of prostaglandin E2 on the human fat cell adenylate cyclase.
    Kather H; Simon B
    J Clin Invest; 1979 Aug; 64(2):609-12. PubMed ID: 457871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium ions amplify prostaglandin E2-induced inhibition of human fat cell adenylate cyclase.
    Kather H
    Horm Metab Res; 1982 Oct; 14(10):556. PubMed ID: 6959955
    [No Abstract]   [Full Text] [Related]  

  • 7. Antagonistic effects of prostaglandin E1 and nicotinic acid on the human fat cell adenylate cyclase.
    Kather H; Simon B
    Res Commun Chem Pathol Pharmacol; 1979 Jan; 23(1):81-8. PubMed ID: 441519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antilipolytic effect of prostaglandin E2 in perifused rat adipocytes.
    Richelsen B; Pedersen SB
    Endocrinology; 1987 Oct; 121(4):1221-6. PubMed ID: 3308432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of prostaglandin action on human fat cell lipolysis.
    Kather H; Zimmer B
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():253-8. PubMed ID: 6221601
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of prazosin on human fat-cell lipolysis and adenylate cyclase activity in vitro.
    Kather H; Daerr W
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S245-7. PubMed ID: 6177966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of adenylate cyclase in adipocyte ghosts by the prostaglandin endoperoxide PGH2.
    Gorman RR; Hamberg M; Samuelsson B
    Adv Prostaglandin Thromboxane Res; 1976; 1():325-30. PubMed ID: 187045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of some naturally occurring prostaglandins of the D-, E-, and I-type and synthetic analogues on adenylate cyclase of human fat cell ghosts.
    Kather H; Simon B
    Res Exp Med (Berl); 1979 Oct; 176(1):25-9. PubMed ID: 392663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulatory and inhibitory effects of catecholamines and of prostaglandin E2 on human fat cell adenylate cyclase.
    Kather H; Simon B
    Adv Cyclic Nucleotide Res; 1981; 14():555-62. PubMed ID: 6945038
    [No Abstract]   [Full Text] [Related]  

  • 14. Down-regulation of prostaglandin E receptors and lipolysis in rat adipocytes.
    Robertson RP; Little SA
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():323-5. PubMed ID: 6133420
    [No Abstract]   [Full Text] [Related]  

  • 15. Antilipolytic action of insulin in abdominal adipocytes of obese subjects before and during energy restriction. Influence of adenosine deaminase.
    Kather H; Scheurer A; Schlierf G
    Int J Obes; 1987; 11(2):191-200. PubMed ID: 3301711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced binding and antilipolytic effect of prostaglandin E2 in adipocytes from patients with hyperthyroidism.
    Richelsen B; Pedersen O; Sørensen NS
    J Clin Endocrinol Metab; 1986 Feb; 62(2):258-62. PubMed ID: 3455691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antilipolytic activity of viprostol, a transdermally active antihypertensive PGE2 analog.
    Crandall DL; Vu V; Lizzo FH; Davis BA; Cervoni P
    Prostaglandins; 1987 May; 33(5):767-73. PubMed ID: 2438724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decrease of prostaglandin E2 receptor binding is accompanied by reduced antilipolytic effects of prostaglandin E2 in isolated rat adipocytes.
    Richelsen B; Beck-Nielsen H
    J Lipid Res; 1985 Jan; 26(1):127-34. PubMed ID: 2857758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of prostaglandins and their methylated analogues upon human adenylate cyclase in the upper gastrointestinal tract.
    Simon B; Kather H; Kommerell B
    Digestion; 1978; 17(6):547-53. PubMed ID: 710739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Islet-activating protein discriminates the antilipolytic mechanism of insulin from that of other antilipolytic compounds.
    Kather H; Aktories K; Schulz G; Jakobs KH
    FEBS Lett; 1983 Sep; 161(1):149-52. PubMed ID: 6350045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.